Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifaximin for Severe Alcoholic Hepatitis
NCT02485106Phase 3Unknown
- Sponsor
- St Vincent's Hospital
- Start
- Jul 2015
- Primary completion
- Dec 2016
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of rifaximin in alcoholic hepatitis (AH), sponsored by St Vincent's Hospital. Status: unknown.
02
Drugs
rifaximin
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on NCT02485106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02485106.